Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 284209 entries
Sorted by: Best Match Show Resources per page
Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12621523
Natl Toxicol Program Tech Rep Ser. 1992 Mar;407:1-289.

C.I. Pigment Red 3, a yellowish red solid, is widely used for coloring paints, inks, plastics, and rubber, and in textile printing. It is used in a wide range of consumer items such as wallpaper, typewriter ribbons, carbon paper,...

Cite
Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1992;407:1-289
(1992). Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program technical report series, 4071-289.
"Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies)." National Toxicology Program technical report series vol. 407 (1992): 1-289.
Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1992 Mar;407:1-289. PMID: 12621523.
Copy Download .nbib Format: NLM
NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12637961
Natl Toxicol Program Tech Rep Ser. 1993 Aug;398:1-235.

Polybrominated biphenyls are synthetic chemicals used as flame retardants. The technical product used in these studies, Firemaster FF-1(R)), is a mixture of brominated biphenyls. Firemaster FF-1(R)) is a known liver carcinogen in rats and mice and is one of...

Cite
NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993;398:1-235
(1993). NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program technical report series, 3981-235.
"NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies)." National Toxicology Program technical report series vol. 398 (1993): 1-235.
NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993 Aug;398:1-235. PMID: 12637961.
Copy Download .nbib Format: NLM
NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12616300
Natl Toxicol Program Tech Rep Ser. 1993 Sep;431:1-285.

Benzyl acetate is used as a flavoring agent in foods, as a fragrance in soaps and perfumes, as a solvent for cellulose acetate and nitrate, and as a component of printing inks and varnish removers. The NTP previously studied...

Cite
NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993;431:1-285
(1993). NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies). National Toxicology Program technical report series, 4311-285.
"NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies)." National Toxicology Program technical report series vol. 431 (1993): 1-285.
NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993 Sep;431:1-285. PMID: 12616300.
Copy Download .nbib Format: NLM
[Tuberculosis in compromised hosts].

Kekkaku : [Tuberculosis]

[No authors listed]
PMID: 14672050
Kekkaku. 2003 Nov;78(11):717-22.

Recent development of tuberculosis in Japan tends to converge on a specific high risk group. The proportion of tuberculosis developing particularly from the compromised hosts in the high risk group is especially high. At this symposium, therefore, we took...

Cite
[Tuberculosis in compromised hosts]. Kekkaku. 2003;78(11):717-22
(2003). [Tuberculosis in compromised hosts]. Kekkaku : [Tuberculosis], 78(11), 717-22.
"[Tuberculosis in compromised hosts]." Kekkaku : [Tuberculosis] vol. 78,11 (2003): 717-22.
[Tuberculosis in compromised hosts]. Kekkaku. 2003 Nov;78(11):717-22. Japanese. PMID: 14672050.
Copy Download .nbib Format: NLM
Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Drugs

Cvetkovic RS, Goa KL.
PMID: 12662125
Drugs. 2003;63(8):769-802. doi: 10.2165/00003495-200363080-00004.

UNLABELLED: Lopinavir is a novel protease inhibitor (PI) developed from ritonavir. Coadministration with low-dose ritonavir significantly improves the pharmacokinetic properties and hence the activity of lopinavir against HIV-1 protease. Coformulated lopinavir/ritonavir was developed for ease of administration and to...

Cite
Cvetkovic RS, Goa KL. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs. 2003;63(8):769-802doi: 10.2165/00003495-200363080-00004.
Cvetkovic, R. S., & Goa, K. L. (2003). Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs, 63(8), 769-802. https://doi.org/10.2165/00003495-200363080-00004
Cvetkovic, Risto S, and Goa, Karen L. "Lopinavir/ritonavir: a review of its use in the management of HIV infection." Drugs vol. 63,8 (2003): 769-802. doi: https://doi.org/10.2165/00003495-200363080-00004
Cvetkovic RS, Goa KL. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs. 2003;63(8):769-802. doi: 10.2165/00003495-200363080-00004. PMID: 12662125.
Copy Download .nbib Format: NLM
Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12571684
Natl Toxicol Program Tech Rep Ser. 2001 Jan;479:5-226.

UNLABELLED: Coconut oil acid diethanolamine condensate, a mixture of fatty acid diethanolamides of the acids found in coconut oil, is widely used in cosmetics, shampoos, soaps, and related consumer products. Because of the lack of information about potential risks...

Cite
Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies). Natl Toxicol Program Tech Rep Ser. 2001;479:5-226
(2001). Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies). National Toxicology Program technical report series, 4795-226.
"Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies)." National Toxicology Program technical report series vol. 479 (2001): 5-226.
Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies). Natl Toxicol Program Tech Rep Ser. 2001 Jan;479:5-226. PMID: 12571684.
Copy Download .nbib Format: NLM
NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice.

Toxicity report series

Bucher JR.
PMID: 17342194
Toxic Rep Ser. 2007 Jan;(72):1-G4.

Sodium dichromate dihydrate is one of a number of inorganic compounds containing hexavalent chromium (CR VI) found in drinking water supplies as a contaminant resulting from various industrial processes including electroplating operations, leather tanning, and textile manufacturing. Because of...

Cite
Bucher JR. NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. Toxic Rep Ser. 2007;(72):1-G4
Bucher, J. R. (2007). NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. Toxicity report series, (72), 1-G4.
Bucher, John R. "NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice." Toxicity report series vol. ,72 (2007): 1-G4.
Bucher JR. NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. Toxic Rep Ser. 2007 Jan;(72):1-G4. PMID: 17342194.
Copy Download .nbib Format: NLM
Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes.

Research report (Health Effects Institute)

Frampton MW, Balmes JR, Bromberg PA, Stark P, Arjomandi M, Hazucha MJ, Rich DQ, Hollenbeck-Pringle D, Dagincourt N, Alexis N, Ganz P, Zareba W, Costantini MG.
PMID: 31898880
Res Rep Health Eff Inst. 2017 Jun;(192):1-107.

INTRODUCTION: Exposure to air pollution is a well-established risk factor for cardiovascular morbidity and mortality. Most of the evidence supporting an association between air pollution and adverse cardiovascular effects involves exposure to particulate matter (PM). To date, little attention...

Cite
Frampton MW, Balmes JR, Bromberg PA, et al. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Res Rep Health Eff Inst. 2017;(192):1-107
Frampton, M. W., Balmes, J. R., Bromberg, P. A., Stark, P., Arjomandi, M., Hazucha, M. J., Rich, D. Q., Hollenbeck-Pringle, D., Dagincourt, N., Alexis, N., Ganz, P., Zareba, W., & Costantini, M. G. (2017). Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Research report (Health Effects Institute), (192), 1-107.
Frampton, M W, et al. "Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes." Research report (Health Effects Institute) vol. ,192 (2017): 1-107.
Frampton MW, Balmes JR, Bromberg PA, Stark P, Arjomandi M, Hazucha MJ, Rich DQ, Hollenbeck-Pringle D, Dagincourt N, Alexis N, Ganz P, Zareba W, Costantini MG. Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes. Res Rep Health Eff Inst. 2017 Jun;(192):1-107. PMID: 31898880.
Copy Download .nbib Format: NLM
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, Rosenberg G, Sagare A, Satizabal CL, Schneider J, Seshadri S, Sur S, Tracy RP, Yasar S, Williams V, Singh H, Mazina L, Helmer KG, Corriveau RA, Schwab K, Kivisäkk P, Greenberg SM.
PMID: 33480172
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

The concept of vascular contributions to cognitive impairment and dementia (VCID) derives from more than two decades of research indicating that (1) most older individuals with cognitive impairment have post mortem evidence of multiple contributing pathologies and (2) along...

Cite
Wilcock D, Jicha G, Blacker D, et al. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement. 2021;17(4):704-715doi: 10.1002/alz.12215.
Wilcock, D., Jicha, G., Blacker, D., Albert, M. S., D'Orazio, L. M., Elahi, F. M., Fornage, M., Hinman, J. D., Knoefel, J., Kramer, J., Kryscio, R. J., Lamar, M., Moghekar, A., Prestopnik, J., Ringman, J. M., Rosenberg, G., Sagare, A., Satizabal, C. L., Schneider, J., Seshadri, S., Sur, S., Tracy, R. P., Yasar, S., Williams, V., Singh, H., Mazina, L., Helmer, K. G., Corriveau, R. A., Schwab, K., Kivisäkk, P., Greenberg, S. M. (2021). MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(4), 704-715. https://doi.org/10.1002/alz.12215
Wilcock, Donna, et al. "MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 17,4 (2021): 704-715. doi: https://doi.org/10.1002/alz.12215
Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, Rosenberg G, Sagare A, Satizabal CL, Schneider J, Seshadri S, Sur S, Tracy RP, Yasar S, Williams V, Singh H, Mazina L, Helmer KG, Corriveau RA, Schwab K, Kivisäkk P, Greenberg SM. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21. PMID: 33480172; PMCID: PMC8122220.
Copy Download .nbib Format: NLM
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, Rosenberg G, Sagare A, Satizabal CL, Schneider J, Seshadri S, Sur S, Tracy RP, Yasar S, Williams V, Singh H, Mazina L, Helmer KG, Corriveau RA, Schwab K, Kivisäkk P, Greenberg SM.
PMID: 33480172
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

The concept of vascular contributions to cognitive impairment and dementia (VCID) derives from more than two decades of research indicating that (1) most older individuals with cognitive impairment have post mortem evidence of multiple contributing pathologies and (2) along...

Cite
Wilcock D, Jicha G, Blacker D, et al. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement. 2021;17(4):704-715doi: 10.1002/alz.12215.
Wilcock, D., Jicha, G., Blacker, D., Albert, M. S., D'Orazio, L. M., Elahi, F. M., Fornage, M., Hinman, J. D., Knoefel, J., Kramer, J., Kryscio, R. J., Lamar, M., Moghekar, A., Prestopnik, J., Ringman, J. M., Rosenberg, G., Sagare, A., Satizabal, C. L., Schneider, J., Seshadri, S., Sur, S., Tracy, R. P., Yasar, S., Williams, V., Singh, H., Mazina, L., Helmer, K. G., Corriveau, R. A., Schwab, K., Kivisäkk, P., Greenberg, S. M. (2021). MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(4), 704-715. https://doi.org/10.1002/alz.12215
Wilcock, Donna, et al. "MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 17,4 (2021): 704-715. doi: https://doi.org/10.1002/alz.12215
Wilcock D, Jicha G, Blacker D, Albert MS, D'Orazio LM, Elahi FM, Fornage M, Hinman JD, Knoefel J, Kramer J, Kryscio RJ, Lamar M, Moghekar A, Prestopnik J, Ringman JM, Rosenberg G, Sagare A, Satizabal CL, Schneider J, Seshadri S, Sur S, Tracy RP, Yasar S, Williams V, Singh H, Mazina L, Helmer KG, Corriveau RA, Schwab K, Kivisäkk P, Greenberg SM. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21. PMID: 33480172; PMCID: PMC8122220.
Copy Download .nbib Format: NLM
Ketogenic diets for drug-resistant epilepsy.

The Cochrane database of systematic reviews

Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN.
PMID: 32588435
Cochrane Database Syst Rev. 2020 Jun 24;6:CD001903. doi: 10.1002/14651858.CD001903.pub5.

BACKGROUND: Ketogenic diets (KDs) are high in fat and low in carbohydrates and have been suggested to reduce seizure frequency in people with epilepsy. Such diets may be beneficial for children with drug-resistant epilepsy. This is an update of...

Cite
Martin-McGill KJ, Bresnahan R, Levy RG, et al. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020;6:CD001903doi: 10.1002/14651858.CD001903.pub5.
Martin-McGill, K. J., Bresnahan, R., Levy, R. G., & Cooper, P. N. (2020). Ketogenic diets for drug-resistant epilepsy. The Cochrane database of systematic reviews, 6CD001903. https://doi.org/10.1002/14651858.CD001903.pub5
Martin-McGill, Kirsty J, et al. "Ketogenic diets for drug-resistant epilepsy." The Cochrane database of systematic reviews vol. 6 (2020): CD001903. doi: https://doi.org/10.1002/14651858.CD001903.pub5
Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020 Jun 24;6:CD001903. doi: 10.1002/14651858.CD001903.pub5. PMID: 32588435; PMCID: PMC7387249.
Copy Download .nbib Format: NLM
Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality.

Acta medica Scandinavica. Supplementum

Palatsi I.
PMID: 16981325
Acta Med Scand Suppl. 1976;599:7-84.

The purpose of this work on patients with myocardial infarction was to find out whether physical rehabilitation based on spontaneous home training can be carried out in practice, and whether such rehabilitation brings about favourable changes in the symptoms,...

Cite
Palatsi I. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality. Acta Med Scand Suppl. 1976;599:7-84
Palatsi, I. (1976). Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality. Acta medica Scandinavica. Supplementum, 5997-84.
Palatsi, I. "Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality." Acta medica Scandinavica. Supplementum vol. 599 (1976): 7-84.
Palatsi I. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality. Acta Med Scand Suppl. 1976;599:7-84. PMID: 16981325.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 284209 entries